Effect of periodic letters on evidence-based drug therapy on prescribing behaviour: A randomized trial

CMAJ. Canadian Medical Association Journal

Volumn 171, Issue 9, 2004, Pages 1057-1061

  Dormuth, Colin R ^a,c,d   Maclure, Malcolm ^b,d   Bassett, Kenneth ^a   Jauca, Ciprian ^a   Whiteside, Carl ^a   Wright, James M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF VICTORIA   (Canada)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANADA; CLINICAL PRACTICE; CONTROLLED STUDY; DATA BASE; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL LITERATURE; PHYSICIAN ATTITUDE; PRESCRIPTION; PUBLICATION;

EID: 7944239184     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: 10.1503/cmaj.1031621     Document Type: Article

References (32)

1. Soumerai SB, McLaughlin TJ, Avorn J. Improving drug prescribing in primary care: a critical analysis. The Milbank Q 1989;67(2):268-317.
2. Oxman AD, Thomson MA, Davis DA, Haynes RB. No magic bullets: a systematic review of 102 trials of interventions to improve professional practice. CMAJ 1995;153:1423-31.
3. Freemantle N, Harvey EL, Wolf F, Grimshaw JM, Grilli R, Bero LA. Effects on professional practice and health outcomes [Cochrane review]. In: The Cochrane Library. Issue 4. Oxford: Update Software; 1999.
4. Davis DA, Thomson MA, Oxman AD, Haynes RB. Evidence for the effectiveness of CME: a review of 50 randomized controlled trials. Med Educ 1992; 268(9):1111-7.
5. Fox RD, Mazmanian PE, Putnam RW, editors. Change and learning in the lives of physicians. New York: Praeger Publishers; 1989.
6. Anderson GM, Lexchin J. Strategies for improving prescribing practice. CMAJ 1996;154;1013-7.
7. Maclure M, Dormuth CR, Naumann T, McCormack J, Rangno R, Whiteside C, et al. Influences of educational interventions and adverse news about calcium channel blockers on first-line prescribing of antihypertensive drugs to elderly people in British Columbia. Lancet 1998;352:943-8.
8. Lacasse Y, Brooks D, Goldstein RS. Trends in the epidemiology of COPD in Canada, 1980-95. COPD and Rehabilitation Committee of the Canadian Thoracic Society. Chest 1999;116(2):306-13.
9. Stang P, Lydick E, Silberman C, Kempel A, Keating ET. The prevalence of COPD: using smoking rates to estimate disease frequency in the general population. Chest 2000;117(5 Suppl 2):354S-9S.
10. Therapeutics Initiative. Treatment of gastro-esophageal reflux disease (GERD). Therapeutics Letter #3, December 1994.
11. Therapeutics Initiative. Anti-infective guidelines for community acquired infections. Therapeutics Letter #5, March 1995.
12. Therapeutics Initiative. Review and update 1995. Therapeutics Letter #9, September 1995.
13. Therapeutics Initiative. Dose titration: minimize to maximize. Therapeutics Letter #10, October 1995.
14. Therapeutics Initiative. New drugs I. Therapeutics Letter #13, March/April 1996.
15. Therapeutics Initiative. Evidence-based drug therapy. What do the numbers mean? Therapeutics Letter #15, August/September/October 1996.
16. Therapeutics Initiative. New drugs II. Therapeutics Letter #17, January 1997.
17. Therapeutics Initiative. New drugs III. Therapeutics Letter #20, July/August 1997.
18. 2-blockers. Therapeutics Letter #1, October 1994.
19. Therapeutics Initiative. Definitive treatment of peptic ulcer disease by eradication of H. pylori. Therapeutics Letter #2, November 1994.
20. Therapeutics Initiative. Should we be using NSAIDs for the treatment of osteoarthritis and "rheumatism"? Therapeutics Letter #4, February 1995.
21. Therapeutics Initiative. Medical management of ischemic heart disease - the optimal use of nitrates. Therapeutics Letter #6, May 1995.
22. Therapeutics Initiative. Drugs of choice in the treatment of hypertension, part 1. Therapeutics Letter #7, June 1995.
23. Therapeutics Initiative. Drugs of choice in the treatment of hypertension, part 2. Therapeutics Letter #8, July/August 1995.
24. Therapeutics Initiative. To sleep or not to sleep. Here are your questions. Therapeutics Letter #11, November/December 1995.
25. Therapeutics Initiative. Changing concepts in the management of asthma. Therapeutics Letter #12, January/February 1996.
26. Therapeutics Initiative. Menopausal hormone therapy. Therapeutics Letter #14, May/June/July 1996.
27. Therapeutics Initiative. Review and update 1996. Therapeutics Letter #16, November/December 1996.
28. Therapeutics Initiative. Management of anxiety disorders in primary care. Therapeutics Letter #18, February/March/April 1997.
29. Therapeutics Initiative. Medical management of benign prostatic hyperpasia. Therapeutics Letter #19, May/June 1997.
30. Avorn J, Soumerai SB. Improving drug therapy decisions through educational outreach. A randomized controlled trial of academically based "detailing." N Engl J Med 1983;308:1457-63.
31. Bjornson DC, Rector TS, Daniels CE, Wertheimer AI, Snowdon DA, Litman TJ. Impact of a drug-use review program intervention on prescribing after publication of a randomized clinical trial. Am J Hosp Pharm 1990;47:1541-6.
32. Denig P, Haaijer-Ruskamp FM, Zijsling DH. Impact of a drug bulletin on the knowledge, perception of drug utility, and prescribing behaviour of physicians. DICP 1990;24:87-92.